HCIT & Life Sciences

We, at AGC, see great promise and market activity in HCIT and Life Sciences technology, having represented venture backed companies to entrepreneurs in their exits with many of the leading acquirers, as well as helping to raise capital to continue our clients’ growth trajectories. A core thesis that we continue to applaud is the intersection of trends in HCIT and Life Sciences technology.  These intersecting technologies not only allow providers to understand patients better, but can also deliver customized experiences in addition to elevating health care engagement.  Building and nurturing technology relationships with patients requires a mindset change not only in HCIT but in Life Sciences.  HCIT and Life Sciences companies are already starting to establish a solid foundation of patient data and using data analytics to understand and address gaps in care.  Life Sciences companies realize that technology is the driving force not only for how they develop therapies, but also for how they go to market, how they collaborate with payers and providers, and engage with their patients. These trends are giving rise to Precision Medicine, through the use of genomics and other technologies such as remote patient monitoring, which is at the intersection of HCIT and Life Sciences technology.

View More Transactions

Sector Team

See our Insights on the Industry and its Sectors


See What Clients Have To Say...

The team at AGC was instrumental in helping drive a successful transaction through a long and intense process to achieve the best outcome that the company and investors could have expected. Their experience in running such a process, as well as their understanding of our industry and knowledge of all the potential partners were crucial factors in achieving such a successful result. I would strongly recommend AGC as a financial advisor. Graham Barnes, Chief Executive Officer, HealthWyse

AGC Partners acted as sole financial advisor to HealthWyse in October, 2016

AGC did a great job bringing us companies we weren't aware of previously. This resulted in us being acquired by a company which was a great strategic fit. The entire AGC team served as a valued advisor and helped make this transaction a success. Jeff Peters, President & CEO of The White Stone Group

AGC Partners acted as sole financial advisor to The White Stone Group in September, 2015

We are very pleased with the team at AGC, who worked tirelessly with us from start to finish and secured a solid outcome for our investors. AGC's extensive knowledge of the Healthcare IT industry and personal guidance throughout the entire term of our engagement was invaluable; I would welcome the opportunity to work with AGC again. Joe Sander, CEO, Harmony

AGC Partners acted as sole financial advisor to Harmony in May, 2014